Infection Prevention Devices Market to Expand at a CAGR of 6.0% during Forecast Period 2019 -2027, TMR Study

In 2018, the worldwide market for 𝐢𝐧𝐟𝐞𝐜𝐭𝐢𝐨𝐧 𝐩𝐫𝐞𝐯𝐞𝐧𝐭𝐢𝐨𝐧 𝐝𝐞𝐯𝐢𝐜𝐞𝐬 reached an estimated worth of around US$ 15.4 billion. Projections indicate a growth trajectory with a compound annual growth rate (CAGR) of 6.0% to Reach ~US$ 25.7 Bn from 2019 to 2027. Key drivers of this expansion include the growing global elderly population, heightened rates of hospital admissions and outpatient visits, and a rising demand for infection prevention products driven by surgical procedures.

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅:
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=69485&utm_source=OpenPR&utm_campaign=MansiR_OpenPR

Healthcare-associated infections (HAIs) are acquired in healthcare settings and pose a significant risk to patient safety. Hand hygiene is crucial for prevention. Employers should implement measures to reduce HAI risk for staff. This includes vaccination for all relevant personnel, not just healthcare providers. Personal protective equipment (PPE) is essential to protect against infectious agents. Risk assessment for infection transmission is vital in general practice.
 
𝐌𝐚𝐣𝐨𝐫 𝐏𝐥𝐚𝐲𝐞𝐫𝐬:
 
Johnson & Johnson (DePuy Synthes),Cardinal Health,PAUL HARTMANN AG,Mölnlycke Health Care AB,3M Healthcare,B. Braun Melsungen AG,Coloplast Group,Ethicon, Inc. (Johnson & Johnson),Medline Industries, Inc.,Becton,Dickinson and Company,C. R. Bard, Inc. (Becton, Dickinson and Company),Hollister Incorporated.
 
𝐈𝐧𝐟𝐞𝐜𝐭𝐢𝐨𝐧 𝐏𝐫𝐞𝐯𝐞𝐧𝐭𝐢𝐨𝐧 𝐃𝐞𝐯𝐢𝐜𝐞𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐓𝐚𝐱𝐨𝐧𝐨𝐦𝐲

Product

Infection Prevention Supplies
Medical Waste Disposable Devices
Infection Prevention Equipment

End User

Hospitals
Lifescience Industries
Clinical Laboratories
Others

𝐃𝐫𝐢𝐯𝐞𝐫𝐬 & 𝐑𝐞𝐬𝐭𝐫𝐚𝐢𝐧𝐭𝐬:

The global geriatric population is growing rapidly, leading to increased hospital visits and surgical procedures, driving demand for laboratory testing and infection prevention devices.

Hospital admissions and outpatient visits are rising, fueling the preference for outpatient care, especially for chronic wound management and surgeries, contributing to the demand for infection prevention devices.

Improvements in survival rates have increased emergency admissions, straining healthcare systems and leading to higher rates of unplanned care, further emphasizing the need for infection prevention measures.

Technological advancements and drug innovations reducing hospital stays may restrain the infection prevention devices market, but infection prevention remains crucial for patient mobility and overall well-being.

Hospital-associated infections are a significant concern due to the invasive nature of modern medical procedures and the increasing number of surgeries, emphasizing the importance of infection control measures in healthcare facilities.

𝐃𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭𝐬:

In 2018, Coloplast A/S acquired IncoCare Gunhild Vieler GmbH, a German direct-to-consumer homecare company, to strengthen its position in Germany. Coloplast and IncoCare plan to bring innovative products and services to more consumers across the country.

In 2019, Hollister Incorporated launched the Infyna Chic intermittent catheter, the latest in its line of female hydrophilic catheter offerings. This new catheter is designed to help provide women who use catheters with a high level of discretion. This product would be added to the complete Infyna portfolio, offering women a variety of options to meet their individual needs.

𝐏𝐥𝐚𝐜𝐞 𝐚𝐧 𝐎𝐫𝐝𝐞𝐫 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐭𝐡𝐞 𝐑𝐞𝐩𝐨𝐫𝐭:
https://www.transparencymarketresearch.com/checkout.php?rep_id=69485<ype=S&utm_source=OpenPR&utm_campaign=MansiR_OpenPR

𝐑𝐞𝐠𝐢𝐨𝐧𝐚𝐥 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧:

North America

North America dominated the global infection prevention devices market in 2018 due to a rise in hospital admissions in the region.
Moreover, outpatient visits and increased demand for infection prevention products due to surgical procedures drives the demand for lifescience reagents.

Europe

The infection prevention devices market in Europe is anticipated to expand at a considerable growth rate in the near future, owing to the presence of a large geriatric population and well-established market players in the region.

Asia Pacific

The global infection prevention devices market in Asia Pacific is projected to expand at a high CAGR during the forecast period, due to a large patient pool and increasing investments in healthcare in countries such as China.

𝐊𝐞𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐭𝐮𝐝𝐲 𝐏𝐨𝐢𝐧𝐭𝐬:

Impact of aging demographics on infection prevention device demand
Adoption trends across different healthcare settings and regions
Regulatory landscape and its influence on market dynamics
Competitive analysis of key market players and their strategies

𝐁𝐫𝐨𝐰𝐬𝐞 𝐌𝐨𝐫𝐞 𝐑𝐞𝐩𝐨𝐫𝐭𝐬 𝐛𝐲 𝐓𝐌𝐑:

𝟑𝐃 𝐏𝐫𝐢𝐧𝐭𝐢𝐧𝐠 𝐌𝐚𝐭𝐞𝐫𝐢𝐚𝐥𝐬 𝐌𝐚𝐫𝐤𝐞𝐭- https://www.globenewswire.com/news-release/2023/03/07/2622254/0/en/3D-Printing-Materials-Market-to-Expand-at-a-CAGR-of-20-4-during-Forecast-Period-2022-2031-TMR-Study.html

𝐏𝐞𝐫𝐜𝐮𝐭𝐚𝐧𝐞𝐨𝐮𝐬 𝐓𝐫𝐚𝐧𝐬𝐥𝐮𝐦𝐢𝐧𝐚𝐥 𝐀𝐧𝐠𝐢𝐨𝐩𝐥𝐚𝐬𝐭𝐲 𝐁𝐚𝐥𝐥𝐨𝐨𝐧𝐬 𝐌𝐚𝐫𝐤𝐞𝐭- https://www.globenewswire.com/news-release/2023/03/07/2622153/0/en/Percutaneous-Transluminal-Angioplasty-Balloons-Market-to-Exceed-US-3-5-Bn-by-End-of-2031.html

𝐀𝐛𝐨𝐮𝐭 𝐓𝐫𝐚𝐧𝐬𝐩𝐚𝐫𝐞𝐧𝐜𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

 

 

𝐂𝐨𝐧𝐭𝐚𝐜𝐭:

Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com       
Email: sales@transparencymarketresearch.com
Follow Us: LinkedIn| Twitter| Blog | YouTube

This release was published on openPR.